Dexamol Plus

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dexamol Plus

Property Description
Active Ingredients Acetaminophen (Paracetamol), Caffeine
Form Oral Solid Dosage Form (Caplet/Tablet)
Pharmacological Class Analgesic Combinations, Central Nervous System (CNS) Stimulant
Common Use Symptomatic relief from pain and fever
Origin Synthetic Compounds

Defining Dexamol Plus: A Fixed-Dose Analgesic Combination

Dexamol Plus is an over-the-counter (OTC) combination medicine classified as an analgesic and antipyretic, formulated to deliver symptomatic relief from common discomforts such as headache and fever. This product is a fixed-dose combination drug, a widely recognized format where its two active ingredients are permanently combined into a single oral solid dosage form for administration. The structure of this combination is clinically recognized for optimizing the effect of the primary pain reliever.

Composition and Pharmacological Class (Acetaminophen, Caffeine)

The medicinal identity of Dexamol Plus is defined by the presence of the two distinct active ingredients: Acetaminophen (Paracetamol) and Caffeine. The formulation belongs to the high-level pharmacological class of Analgesic Combinations, integrating the core P-Aminophenol derivative with the xanthine derivative Caffeine. This specific pairing is used in similar fixed-dose formulations worldwide, marking Dexamol Plus as a formulation designed for broad accessibility. The stimulant Caffeine functions strictly as an adjuvant, an ingredient included specifically to enhance the pain-relieving efficacy of the primary agent.

What is the General Therapeutic Purpose of the Combination?

The general therapeutic purpose of Dexamol Plus is to provide a coordinated and enhanced effort toward pain relief and the reduction of fever during general malaise, such as when experiencing cold or flu symptoms. The inclusion of the CNS stimulant Caffeine ensures that the product delivers a functionally superior outcome compared to single-agent dosing. This effect leverages Caffeine’s mild stimulant properties to help boost the activity of the pain reliever, a strategic approach in pharmaceutical design aimed at improving patient response to common discomforts. This focus positions Dexamol Plus for individuals seeking rapid, enhanced relief from acute, moderate discomfort.

Regulatory References

  1. Central Nervous System (CNS) Stimulants

What side effects are possible with Dexamol Plus?

Possible Side Effects and Safety Information

The official safety profile for this medicine is structured by regulatory agencies (such as the FDA, EMA, and Health Canada) to clearly communicate documented risks and necessary precautions.

Adverse Reaction Scope

Adverse reactions are formally grouped by how often they occur and by the body system affected (System-Organ-Class). While the exact frequency may vary, documented side effects for its active ingredients typically involve:

  • Nervous System Effects: May include dizziness, sedation, or mild confusion.
  • Gastrointestinal Effects: May include nausea or stomach discomfort.

Serious Adverse Reactions

Regulatory documentation highlights serious adverse reactions that require immediate medical attention. These are typically rare but are critical to note. Key risks documented for the components of Dexamol Plus include:

  • Severe Liver Damage (Hepatotoxicity): This risk is primarily associated with the paracetamol component, especially when the maximum recommended daily dose is exceeded or when taken with alcohol.
  • Severe Skin Reactions: Rare but serious adverse events such as Stevens-Johnson Syndrome (SJS) have been documented.
  • Allergic Reactions: Signs of a severe allergic reaction (anaphylaxis) require urgent care.

Safety Restrictions and Limitations

Contraindications define conditions where the medicine must not be used. These restrictions are regulatory statements and often include individuals with severe liver impairment or those currently taking certain types of medication, such as Monoamine Oxidase Inhibitors (MAOIs).

Population-Specific Warnings often apply to pregnant and breastfeeding women, and caution is advised for patients with existing liver or kidney disease. Use in these groups requires specific consideration, as detailed in the official label.

Regulatory Safety Summary

Government health authorities require that all safety information is communicated through a clear framework:

  • Categorization: Side effects are classified by their likelihood (e.g., Rare, Uncommon) and the affected body system.
  • Critical Alerts: Contraindications and Warnings are placed at the forefront to manage the most significant risks, such as dose-related hepatic toxicity. The safety profile is structured to ensure patients and healthcare providers understand both common and serious risks based on officially reviewed data.

Overdose and Emergency Response

Overdose and When to Seek Help

The information presented is derived exclusively from the overdose sections of governmental regulatory documents.

Overdose Manifestations and Outcomes Required Emergency Actions
Overdose manifests initially with non-specific symptoms such as nausea, vomiting, abdominal pain, and loss of appetite. Delayed signs of severe hepatic injury, including jaundice, dark-colored urine, and light-colored feces, may subsequently appear. The caffeine component can also present as nervousness, palpitations, or cardiac arrhythmias. Severe liver damage and life-threatening hepatic failure are documented outcomes of this overdose. Immediate medical attention must be sought for any suspected overdose. This action is required even if the person appears to feel well, due to the significant and potentially delayed risk of serious liver damage from the acetaminophen component. Contact Poison Help or emergency services.

Antidote and Clinical Management

Acetylcysteine (N-acetylcysteine, N-A-C) is the specific antidote for acetaminophen overdose and is indicated to prevent or lessen hepatic injury. Regulatory protocols require urgent assessment of plasma concentrations and comprehensive monitoring of hepatic and renal function. The overdose hazard is specifically noted as greater in patients with non-cirrhotic alcoholic liver disease.

Therapeutic Uses of Dexamol Plus

Dexamol Plus is commonly used to help with symptomatic relief across several therapeutic domains, applied in situations where symptoms create noticeable discomfort. It contributes to improving comfort during periods of heightened symptoms and may help patients cope more steadily with symptom fluctuations. The medication is applied across domains where additional symptomatic support is needed, consistent with its therapeutic classification.

Therapeutic Areas

The medication is generally applied in addressing symptom clusters that may become intense or disruptive, and is considered relevant for easing symptoms related to physical discomfort such as tension headaches, generalized body aches, toothache, and menstrual cramps. It is also commonly used to help with symptom clusters that may appear suddenly, relevant for managing symptoms related to systemic imbalance, such as fever and accompanying body aches associated with the common cold or flu.

The combination may also assist with symptoms that interfere with daily functioning, such as associated fatigue and lethargy. This supportive relief is considered relevant in contexts involving heightened systemic burden.

“The therapeutic benefit contributes to easing the overall symptom load, and is generally relevant when supportive symptom management is appropriate.”


Quick Fact: Symptomatic Relief

The medication helps patients cope more steadily with symptom fluctuations and supports improved day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Dexamol Plus?

This section defines the official eligibility for Dexamol Plus, based strictly on the population restrictions documented by government regulatory bodies for this fixed-dose combination of Acetaminophen (Paracetamol) and Caffeine.


Approved and Restricted Populations

Population Group Official Eligibility Status
Adults and Adolescents Approved for use (typically ge 12 to 16 years of age and older, depending on license)
Children under Minimum Age Not recommended; safety and efficacy are not established in the combination for younger pediatric groups
Mild to Moderate Organ Impairment Conditional use; requires caution due to potential risk of component accumulation
Pregnancy Not recommended, primarily due to the Caffeine component
Breastfeeding Contraindicated (Both active ingredients pass into breast milk)

Absolute Non-Eligibility (Contraindications)

The medicine is absolutely contraindicated (must not be used) in several specific patient populations:

  • Hypersensitivity: Individuals with a known allergy to Acetaminophen, Caffeine, or any non-active ingredient in the product.
  • Severe Hepatic Impairment: Patients with severe active liver disease or non-cirrhotic alcoholic liver disease are formally excluded due to the significant risk of toxicity from Acetaminophen.
  • Severe Renal Impairment: Use is contraindicated in patients with compromised kidney function defined as severe impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Profile Restrictions

Co-administration with any other product containing Acetaminophen (Paracetamol) is formally prohibited in regulatory documentation to prevent the risk of exceeding the daily dose limit and subsequent acute liver failure. The label requires a mandatory warning regarding the significant risk of severe liver damage if a person consumes three or more alcoholic drinks every day while using the Acetaminophen component. This high-risk interaction is tied to the induction of the CYP2E1 enzyme.

Documented Drug and Substance Interactions

  • Oral Anticoagulants: Prolonged use of high doses of the Acetaminophen component is documented to potentiate the hypoprothrombinemic effect of Warfarin, necessitating close monitoring.
  • CYP1A2 Modifiers: The Caffeine component's plasma exposure is officially altered by substances that modify the CYP1A2 enzyme. For example, Tobacco Smoke (an inducer) increases clearance, while certain medications (inhibitors) can increase the drug's concentration.
  • Pharmacodynamic Agents: The product may produce additive stimulation effects when co-administered with other Xanthine Derivatives such as Theophylline.
  • Population Note: The risk of Acetaminophen-induced toxicity is formally heightened in individuals with underlying liver disease.

Connection to the Overall Interaction Profile

The product’s interaction structure is defined by two critical constraints: the absolute prohibition of duplicate Acetaminophen therapy and the metabolic constraints related to CYP enzyme modulation by alcohol and other drugs, which can significantly alter the product's risk profile or exposure.

Mechanism of Action

How Dexamol Plus Works — Mechanism of Action

The mechanism of action for Dexamol Plus involves two distinct components that modulate key signaling pathways in the central nervous system.

Central Modulation of Pain and Temperature

The paracetamol component primarily exerts its effect by acting within domains involving enzyme-mediated signaling. It is a weak inhibitor of Cyclooxygenase (COX) enzymes, mainly in the brain, which reduces the synthesis of prostaglandin E2 ( PGE2). This molecular modification of early steps in the prostaglandin cascade results in two core physiological adjustments: an elevated central pain threshold and the resetting of the hypothalamic thermoregulatory center.


Antagonism of Inhibitory CNS Signaling

The caffeine component engages mechanisms that regulate purinergic processes by acting as a non-selective antagonist of adenosine receptors ( A1 and A2A) in the CNS. By blocking the natural inhibitory effects of adenosine, caffeine initiates a signaling sequence that increases neuronal activity and promotes cerebral vasoconstriction. This distinct pathway modulation enhances the activity of the primary analgesic mechanism.

Dosage and Administration Information

How to Use Dexamol Plus: Official Administration Guidelines

This section explains the general principles of administering the Acetaminophen (Paracetamol) and Caffeine fixed-dose combination, referred to as Dexamol Plus.


Dosing and Frequency for Oral Use

Usage Guideline Official Instruction
Administration Route The medicine is intended for oral administration only, typically as a tablet or caplet.
Adult Single Dose The standard single dose is two tablets (delivering 1000 mg Acetaminophen).
Frequency Doses are to be repeated every 4 to 6 hours, as needed. The minimum interval between doses is 4 hours.
Maximum Daily Limit Not to exceed eight tablets in any 24-hour period, which corresponds to 4000 mg of Acetaminophen.

Administration Conditions and Constraints

The oral solid dosage form must be swallowed whole with water. The tablet may be split for ease of ingestion, but both halves must be consumed immediately. Official guidance stipulates that the medicine should not be taken concurrently with any other medicinal product containing acetaminophen (paracetamol). Furthermore, users are instructed to limit the intake of other sources of caffeine to ensure that the maximum daily limit is not exceeded.

Population and Duration Rules

For adolescents aged 12 to 15 years, the dose is generally restricted to one tablet every 4 to 6 hours, with a maximum of four tablets in 24 hours. Use is not recommended for children under 12 years of age. The treatment duration for pain relief should not exceed 5 days and for fever should not exceed 3 days, unless continuation is specifically advised by a healthcare professional.

Recent Clinical Evidence

Research Examining Minor Aches and Pains

Research has explored how Dexamol Plus, or its core components, was included in studies examining outcomes related to physical discomfort such as headaches and toothaches. These studies often take the form of short-term Randomized Controlled Trials (RCTs) where different study compounds are compared to understand how symptoms change over defined time intervals. The outcomes that were measured often included patient-reported outcomes describing perceived discomfort and changes in pain intensity scores recorded at defined time intervals following administration of the study compound. Studies conducted during periods of increased symptom activity reported observed changes in the measured outcomes of pain intensity in the observed populations, particularly within the first few hours. Long-term effects are not fully established, and the research findings reflect the specific populations and conditions studied.


Research Examining Body Temperature Change

Research has been conducted to evaluate the relationship between Dexamol Plus, or its components, and body temperature change over time. Studies generally examined outcomes related to systemic or functional imbalance by monitoring physiological strain in adults and adolescents presenting with fever. Studies monitored how body temperature evolved in the observed populations over short intervals, typically 4 to 6 hours after a single dose. Few data are available for the specific Dexamol Plus combination, and follow-up durations were limited to the short term.


What is Still Uncertain About Dexamol Plus Research

Several limitations and gaps exist in the current research landscape. Sample sizes were modest in some comparative trials, and evidence quality varies across studies based on design and duration. Limited information for long-term outcomes is available, and research is ongoing in certain areas. The findings reflect the populations included in the studies, and research cannot predict whether individuals outside these groups will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Dexamol Plus (FAQ)


Q: Does Dexamol Plus contain any ingredients other than the main one?

A: Official product labeling for Dexamol Plus is required to disclose all ingredients, including both the active medicinal components and the non-active ingredients, or excipients. This full disclosure supports patients in checking for any known allergies to components of the product.


Q: Are there any common foods or beverages that interact with Dexamol Plus?

A: Regulatory warnings note that limiting the use of other caffeine-containing foods or beverages is recommended while taking this medicine. This precaution is intended to prevent consuming excessive levels of caffeine, which can lead to unwanted effects, as described in official product information.


Q: Can older adults typically use Dexamol Plus?

A: Official guidance notes that caution is advised for older adults when using this medicine. This is due to the potential for age-related changes in organ function, such as kidney or liver function, which might affect how the medicine is processed in the body.


Q: Are there any specific supplements or vitamins that should be avoided when taking Dexamol Plus?

A: Regulatory instructions indicate that information about all other supplements, vitamins, and herbal products being used should be discussed with a healthcare professional. This discussion is important because some supplements may interfere with how the medicine works or is metabolized in the body, which is a known risk described in drug interaction profiles.


Q: What should be done if a potential serious side effect is noticed while taking Dexamol Plus?

A: Official warnings explicitly state that if severe symptoms occur, such as signs of a severe allergic reaction or a severe skin reaction, official warnings describe that in these instances, use of the medicine is required to be stopped immediately. Official documentation states that immediate medical help is necessary.


Q: What is the regulatory status of Dexamol Plus in major global health markets?

A: Regulatory bodies in major markets generally classify this product as an over-the-counter (OTC) combination medicine. It is classified for symptomatic relief of common discomforts like pain and fever, reflecting its accessibility to the public for non-prescription use.


Q: Do studies suggest Dexamol Plus loses effectiveness over time?

A: Regulatory guidelines caution that frequent or excessive use of analgesics, especially those containing caffeine, may lead to a complication known as medication-overuse headache. This is a specific side effect related to the long-term or sustained use of the product.


Q: Does Dexamol Plus interact with herbal remedies?

A: Official guidance indicates that all other medications, vitamins, and herbal products being used should be discussed with a healthcare professional. This discussion helps ensure there are no potential interactions that could alter the risk profile of the medicine, as described in regulatory documentation.


Q: Are there special warnings about taking Dexamol Plus with other central nervous system depressants?

A: Official warnings note that caution is generally advised when combining central nervous system (CNS) stimulants, such as caffeine, with other medicines that may also cause sedation. This is to avoid unwanted effects on the nervous system, as outlined in the official interactions section.


Q: Is Dexamol Plus the same as regular Dexamol?

A: Official documentation classifies Dexamol Plus as a fixed-dose combination containing two active components: Acetaminophen and Caffeine. Versions referred to as 'regular' typically contain only Acetaminophen as a single ingredient, distinguishing the two formulations.


Q: How quickly can someone generally expect Dexamol Plus to start working?

A: Pharmacokinetic data indicates that the onset of action for the primary analgesic component when taken orally is approximately 37 minutes. The addition of caffeine to the combination may result in accelerated absorption of the pain reliever.


Q: Is there a risk of developing a physical dependency on Dexamol Plus?

A: The caffeine component, when consumed regularly in high amounts, may be associated with mild physical dependence. Sudden cessation in high-use scenarios could potentially lead to withdrawal symptoms, such as headaches.


Q: Can Dexamol Plus be used by people with a history of heart conditions?

A: Official warnings note that caution is advised for individuals with pre-existing high blood pressure or other cardiovascular conditions. This is because these types of agents can cause a temporary increase in heart rate and blood pressure, as noted in the safety profile.


Q: Where can I find official regulatory documents about Dexamol Plus?

A: Official product information, including the full prescribing information and patient leaflet, is publicly available on government websites. Examples include the FDA’s DailyMed or the EMA’s Summary of Product Characteristics (SmPC) for the specific formulation.


Q: Is Dexamol Plus classified as a controlled substance in any countries?

A: The active components, Acetaminophen and Caffeine, are generally not classified as controlled substances in major regulatory systems. Controlled substance status is typically reserved for combination products containing controlled ingredients like opioids, which are not present in Dexamol Plus.


Q: Does Dexamol Plus affect blood pressure readings?

A: Official documentation related to the caffeine component describes it as a central nervous system stimulant. This stimulant effect can cause a short-term increase in both heart rate and blood pressure, as described in regulatory documentation.


Q: How long does Dexamol Plus typically stay in the body?

A: Pharmacokinetic data indicates the elimination half-life for the primary analgesic component is approximately 1.9 to 2.5 hours. However, the total time it stays in the body can vary based on individual metabolism and other health factors.


Q: Does Dexamol Plus have a generic alternative available?

A: Regulatory documents often confirm that the fixed-dose combination product has therapeutic equivalence to generic versions. These therapeutically equivalent generic products may be commercially available, depending on the region.


Q: Can Dexamol Plus be taken with or without food?

A: Official patient labeling typically states that the medicine may be taken with or without food. Product information notes that taking the medicine with food may help if mild stomach upset is experienced, as noted in the administration conditions.


Q: Are headaches a known side effect of Dexamol Plus?

A: Regulatory warnings note that frequent or excessive use of this medicine may lead to the development of a complication known as medication overuse headache. This is a specific risk associated with the overuse of analgesic products, as described in official documentation.


Q: Can Dexamol Plus interact with birth control pills?

A: Research cited in regulatory-related interactions documentation suggests that some components of oral contraceptives may affect the concentration of the product's components. This occurs by potentially altering the activity of liver enzymes responsible for drug breakdown.


Q: Is Dexamol Plus described as a first-line treatment for its indication?

A: For its approved indications, studies and official information indicate the combination is described in some clinical guidelines as a recommended or first-line option for managing acute pain episodes like tension headaches.

How should Dexamol Plus be stored and disposed of?

How to Store and Dispose of Dexamol Plus?

The storage and disposal of Dexamol Plus must adhere strictly to official regulatory requirements to maintain product stability and ensure safety.

Required Storage Conditions

Condition Requirement
Temperature Store below 25 C.
Child Safety Keep out of the reach and sight of children and/or infants.

Product Stability and Expiration

The medicine must not be used after the expiry date printed on the package. The expiry date corresponds to the last day of the stated month. If the product is packaged in a bottle, it can be used until the printed expiry date, even after the bottle has been opened.

Official Disposal Instructions

Regulatory instructions prohibit discarding Dexamol Plus via wastewater or household trash. Unused or expired medicine must be disposed of properly by asking a pharmacist for guidance on authorized take-back or disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dexamol Plus found in:

A-Z Index: